Nuvectra Corp
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | |
|---|---|---|---|
| Revenue | $48.8M | $27.1M | $12.5M |
| Operating income | −$43.2M | −$42.2M | −$37.4M |
| Net income | −$48.1M | −$44.6M | −$38.4M |
| Total assets | $158.0M | $91.1M | $119.3M |
| Total liabilities | $65.1M | $42.9M | $30.7M |
| Equity | $92.9M | $48.2M | $88.6M |
| EPS (diluted) | $-3.25 | $-4.22 | $-3.74 |
| Shares out. | 14.1M | 10.3M | 10.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- −88.4%
- Net margin
- −98.6%
- Return on equity
- −51.8%
- Return on assets
- −30.5%
- Return on capital (ROCE)
- −31.4%
- Liabilities / assets
- 41.2%
- Debt / equity
- 0.70×
- Book value / share
- $6.58
- Revenue growth (YoY)
- 80.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- 1.16grey zone
- Accruals / assets
- −6.0%clean
- Beneish M-Score
- -2.53normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 warning● 3 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Altman Z″ in the grey zone
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Regulation FD disclosure · Other material eventApr 20, 2020
- Regulation FD disclosure · Other material eventMar 25, 2020
- Other material eventMar 16, 2020
- Regulation FD disclosureFeb 13, 2020
- Other material eventJan 31, 2020
- Regulation FD disclosure · Other material eventJan 15, 2020
- Regulation FD disclosure · Other material eventDec 31, 2019
- Costs from exit or disposal · Director / officer change · Other material eventNov 22, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 16, 2021
- 8-KFORM 8-KApr 20, 2020
- 8-KFORM 8-KMar 25, 2020
- 8-KFORM 8-KMar 16, 2020
- SC 13GSCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIPFeb 14, 2020
- SC 13G/ASCHEDULE 13G/AFeb 14, 2020
- 8-KFORM 8-KFeb 13, 2020
- 8-KFORM 8-KJan 31, 2020
- 8-KFORM 8-KJan 15, 2020
- 8-KFORM 8-KDec 31, 2019
- 4RSU VESTDec 26, 2019
- 4RSU VESTDec 26, 2019
- 4RSU VESTDec 26, 2019
- 25-NSEDec 17, 2019
- 4RSU VESTDec 16, 2019
Corporate family
Spun off from GreatbatchITGR · Feb 24, 2016
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.